Trial of early, goal-directed resuscitation for septic shock

New England Journal of Medicine

Volumn 372, Issue 14, 2015, Pages 1301-1311

  Mouncey, Paul R ^a   Osborn, Tiffany M ⁱ   Power, G Sarah ^a   Harrison, David A ^a   Sadique, M Zia ^b   Grieve, Richard D ^b   Jahan, Rahi ^a   Harvey, Sheila E ^a   Bell, Derek ^c,d   Bion, Julian F ^f   Coats, Timothy J ^g   Singer, Mervyn ^e   Young, J Duncan ^h   Rowan, Kathryn M ^a  

^a and London School of Hygiene Tropical Medicine   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d CHELSEA AND WESTMINSTER HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^g UNIVERSITY OF LEICESTER   (United Kingdom)

^h UNIVERSITY OF OXFORD   (United Kingdom)

ⁱ WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DOBUTAMINE; HYPERTENSIVE FACTOR; INFUSION FLUID; VASOACTIVE AGENT; ANTIINFECTIVE AGENT; VASOCONSTRICTOR AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; EARLY GOAL DIRECTED THERAPY; EARLY INTERVENTION; ERYTHROCYTE TRANSFUSION; FEMALE; HEALTH CARE UTILIZATION; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; ORGAN DYSFUNCTION SCORE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RESUSCITATION; RISK ASSESSMENT; RISK REDUCTION; SEPTIC SHOCK; TREATMENT OUTCOME; BLOOD TRANSFUSION; CLINICAL PROTOCOL; CLINICAL TRIAL; COST BENEFIT ANALYSIS; ECONOMICS; FLUID THERAPY; INTRAVENOUS DRUG ADMINISTRATION; KAPLAN MEIER METHOD; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PRACTICE GUIDELINE; PROCEDURES; QUALITY ADJUSTED LIFE YEAR; SHOCK, SEPTIC;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BLOOD TRANSFUSION; CLINICAL PROTOCOLS; COMBINED MODALITY THERAPY; COST-BENEFIT ANALYSIS; FEMALE; FLUID THERAPY; HUMANS; INFUSIONS, INTRAVENOUS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; RESUSCITATION; SHOCK, SEPTIC; VASOCONSTRICTOR AGENTS;

EID: 84926301084     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1500896     Document Type: Article

References (26)

1. Jawad I, Lukšić I, Rafnsson SB. Assessing available information on the burden of sepsis: global estimates of incidence, prevalence and mortality. J Glob Health 2012;2(1):010404.
2. Levy MM, Artigas A, Phillips GS, et al. Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study. Lancet Infect Dis 2012;12:919-24.
3. Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. JAMA 2014;311: 1308-16.
4. Cuthbertson BH, Elders A, Hall S, et al. Mortality and quality of life in the five years after severe sepsis. Crit Care 2013; 17:R70.
5. Torio CM, Andrews RM. Healthcare Cost and Utilization Project (HCUP) statistical briefs - national inpatient hospital costs: the most expensive conditions by payer, 2011. Statistical brief #160. Rockville, MD: Agency for Health Care Policy and Research, 2013.
6. Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004;32:858-73. [Errata, Crit Care Med 2004;32:1448, 2169-70.]
7. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296-327.
8. Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013;41:580-637.
9. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345:1368-77.
10. Ho BC, Bellomo R, McGain F, et al. The incidence and outcome of septic shock patients in the absence of earlygoal directed therapy. Crit Care 2006;10: R80.
11. Chapman M, Gattas D, Suntharalingam G. Why is early goal-directed therapy successful - is it the technology? Crit Care 2005;9:307-8.
12. The ProCESS Investigators. A randomized trial of protocol-based care for early septic shock. N Engl J Med 2014; 370:1683-93.
13. The ARISE Investigators and the ANZICS Clinical Trials Group. Goal-directed resuscitation for patients with early septic shock. N Engl J Med 2014; 371:1496-506.
14. The ProCESS/ARISE/ProMISe Methodology Writing Committee. Harmonizing international trials of early goal-directed resuscitation for severe sepsis and septic shock: methodology of ProCESS, ARISE, and ProMISe. Intensive Care Med 2013; 39:1760-75.
15. Reade MC, Delaney A, Bailey MJ, et al. Prospective meta-analysis using individual patient data in intensive care medicine. Intensive Care Med 2010;36:11-21.
16. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992;101:1644-55.
17. Mental Capacity Act 2005. London: The Stationery Office, 2005.
18. Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure: on behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996;22: 707-10.
19. Critical Care Minimum Dataset Full Specification (CCMDS). London: Information Standards Board for Health and Social Care, March 2010.
20. Harrison DA, Brady AR, Rowan K. Case mix, outcome and length of stay for admissions to adult, general critical care units in England, Wales and Northern Ireland: the Intensive Care National Audit & Research Centre Case Mix Programme database. Crit Care 2004;8:R99-R111.
21. Harvey SE, Elbourne D, Ashcroft J, Jones CM, Rowan K. Informed consent in clinical trials in critical care: experience from the PAC-Man Study. Intensive Care Med 2006;32:2020-5.
22. Power GS, Harrison DA, Mouncey PR, Osborn TM, Harvey SE, Rowan KM. The Protocolised Management in Sepsis (ProMISe) trial statistical analysis plan. Crit Care Resusc 2013;15:311-7.
23. Shapiro NI, Wolfe RE, Moore RB, Smith E, Burdick E, Bates DW. Mortality in Emergency Department Sepsis (MEDS) score: a prospectively derived and validated clinical prediction rule. Crit Care Med 2003;31:670-5.
24. Guide to the methods of technology appraisal. London: National Institute for Health and Care Excellence, 2013.
25. Ara R, Brazier JE. Populating an economic model with health state utility values: moving toward better practice. Value Health 2010;13:509-18.
26. Levy MM, Rhodes A, Phillips GS, et al. Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5-year study. Crit Care Med 2015;43:3-12.